Home / Drug Shortage Tracker Drug shortages
Drug Shortage Tracker Which medications are currently in short supply, from the FDA Drug Shortage Database, with the affected manufacturers.
Compiled by PlainMeds , Drug Information Editorial Process Data updated 2026-05-15
71 Active shortages
Data from the FDA Drug Shortage Database, updated as the FDA publishes changes. See our methodology .
PlainMeds tracks 71 active FDA drug shortages, showing which medications are in short supply, the affected manufacturers, and links to each drug profile.
A drug shortage means a medication is in short supply relative to demand, tracked in the FDA Drug Shortage Database. PlainMeds lists 71 currently active shortages with the affected products and manufacturers. A shortage may not affect every pharmacy or formulation, and the status changes as the FDA updates its database. Educational information, not medical advice.
Current Shortages (71) Available Noven Pharmaceuticals, Inc. Dec 18, 2025
Available XGen Pharmaceuticals DJB, Inc. Jan 8, 2026
Available Fresenius Kabi USA, LLC Feb 25, 2026
Available Takeda Pharmaceuticals USA Inc. Jan 9, 2026
["Anti-Infective","Pediatric"] Unavailable Hikma Pharmaceuticals USA, Inc. Mar 12, 2026
Unavailable Bausch & Lomb Incorporated Nov 17, 2025
Limited Availability Caplin Steriles, Ltd. Mar 2, 2026
Available Baxter Healthcare Mar 4, 2026
Available Chartwell Molecular Holdings LLC Feb 2, 2026
Unavailable Teva Pharmaceuticals USA, Inc. Mar 16, 2026
["Neurology","Pediatric","Psychiatry"] Available Rubicon Research Private Limited Jan 5, 2026
Available Granules Pharmaceuticals Inc. Mar 2, 2026
Available Chartwell Molecular Holdings LLC Feb 2, 2026
["Cardiovascular","Pediatric","Renal"] Available Baxter Healthcare Mar 4, 2026
Unavailable Baxter Healthcare Mar 4, 2026
["Anesthesia","Neurology"] Available WG Critical Care Mar 2, 2026
Available Caplin Steriles, Ltd. Mar 2, 2026
Unavailable Accord Healthcare Inc. Feb 17, 2026
Unavailable Accord Healthcare Inc. Feb 17, 2026
Available Amneal Pharmaceuticals Feb 9, 2026
Unavailable Teva Pharmaceuticals USA, Inc. Mar 2, 2026
Available Fera Pharmaceuticals Sep 17, 2025
Available Sanofi-Aventis U.S. LLC Sep 17, 2025
Available Fresenius Kabi USA, LLC Mar 17, 2026
Unavailable Apotex Corp. Mar 17, 2026
Limited Availability Harrow Eye, LLC Sep 17, 2025
Unavailable Medexus Sep 17, 2025
Available Spectra Medical Devices, LLC Feb 19, 2026
["Endocrinology/Metabolism"] Available Hikma Pharmaceuticals USA, Inc. Mar 12, 2026
Limited Availability pharmaand GmbH (pharma&) Aug 19, 2025
Available Armas Pharmaceuticals Inc Feb 18, 2026
Available Hospira, Inc., a Pfizer Company Mar 13, 2026
["Dermatology","Endocrinology/Metabolism","Gastroenterology","Hematology","Neurology","Oncology","Ophthalmology","Other","Pulmonary/Allergy","Rheumatology"] Unavailable Hikma Pharmaceuticals USA, Inc. Mar 12, 2026
["Gastroenterology","Other","Pediatric"] Unavailable Baxter Healthcare Mar 4, 2026
Unavailable Baxter Healthcare Mar 4, 2026
Available Baxter Healthcare Mar 4, 2026
["Endocrinology/Metabolism","Gastroenterology","Other","Pediatric"] Available Baxter Healthcare Mar 4, 2026
["Endocrinology/Metabolism","Gastroenterology","Other","Pediatric"] Available Baxter Healthcare Mar 4, 2026
["Endocrinology/Metabolism","Gastroenterology","Other","Pediatric"] Available Baxter Healthcare Mar 4, 2026
Limited Availability Amneal Pharmaceuticals Feb 9, 2026
Limited Availability Curium US LLC Mar 18, 2026
Unavailable Fresenius Kabi USA, LLC Feb 25, 2026
Available Ailex Pharmaceuticals Mar 2, 2026
Limited Availability Trigen Laboratories, LLC Mar 2, 2026
["Anesthesia","Pediatric"] Unavailable Hospira, Inc., a Pfizer Company Mar 13, 2026
Unavailable Fresenius Kabi USA, LLC Feb 25, 2026
Available Hospira, Inc., a Pfizer Company Mar 13, 2026
["Rheumatology","Oncology"] Available Hikma Pharmaceuticals USA, Inc. Mar 12, 2026
Limited Availabiltiy Nephron Pharmaceuticals Corporation Jan 7, 2026
["Anesthesia","Neurology","Pediatric"] Unavailable Accord Healthcare Inc. Feb 17, 2026
Limited Availability Amphastar Pharmaceuticals, Inc. Mar 3, 2026
["Endocrinology/Metabolism","Gastroenterology","Pediatric"] Available Long Grove Pharmaceuticals LLC Jan 5, 2026
Available MSN Laboratories Private Limited Feb 3, 2026
["Analgesia/Addiction","Pediatric"] Available Fresenius Kabi USA, LLC Feb 25, 2026
Unavailable Hikma Pharmaceuticals USA, Inc. Mar 12, 2026
["Endocrinology/Metabolism","Gastroenterology","Pediatric","Total Parenteral Nutrition"] Available Hikma Pharmaceuticals USA, Inc. Mar 12, 2026
Available Hikma Pharmaceuticals USA, Inc. Mar 12, 2026
Unavailable Fresenius Kabi USA, LLC Feb 25, 2026
Available EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.) Mar 16, 2026
["Pulmonary/Allergy","Pediatric"] Available Nephron Pharmaceuticals Corporation Jan 7, 2026
Unavailable Cumberland Pharmaceuticals Inc. Mar 16, 2026
["Endocrinology/Metabolism","Gastroenterology","Pediatric"] Limited Availability Amphastar Pharmaceuticals, Inc. Mar 3, 2026
Available Hikma Pharmaceuticals USA, Inc. Mar 12, 2026
Available Baxter Healthcare Mar 4, 2026
Available Laboratorios Atral Mar 6, 2026
["Analgesia/Addiction","Pediatric"] Unavailable Hikma Pharmaceuticals USA, Inc. Mar 12, 2026
["Analgesia/Addiction","Gastroenterology","Other","Pulmonary/Allergy"] Unavailable XGen Pharmaceuticals DJB, Inc. Jan 8, 2026
Limited Availability Lupin Pharmaceuticals, Inc. Mar 2, 2026
Available Takeda Pharmaceuticals USA Inc. Jan 9, 2026
["Anti-Infective","Ophthalmology"] Unavailable Padagis US LLC Feb 4, 2026
Unavailable Rising Pharma Holdings, Inc. Jan 14, 2026
To Be Discontinued (172) Discontinuation of the manufacture of the drug
Discontinuing Amneal Pharmaceuticals
A business decision was made to discontinue. Distribution will end April 2026. The 200 mg/2 mL injection presentation (NDC 0002-3116-11) will remain.
Discontinuing Eli Lilly and Co.
Discontinuation of the manufacture of the drug
Discontinuing Upsher-Smith Laboratories, LLC
Discontinuation of the manufacture of the drug
Discontinuing Takeda Pharmaceuticals USA Inc.
Discontinuation of the manufacture of the drug
Discontinuing Sanofi-Aventis U.S. LLC
Discontinuation of the manufacture of the drug.
Discontinuing Pfizer Inc.
Discontinuation of private label only
Discontinuing Sandoz Inc.
A business decision was made to discontinue manufacture of the drug
Discontinuing Teva Pharmaceuticals USA, Inc.
Discontinuation of the manufacture of the drug
Discontinuing Fresenius Medical Care North America
Discontinuation of the manufacture of the drug
Discontinuing Merck Sharp & Dohme Corp.
Discontinuation of the manufacture of the drug
Discontinuing Advanz Pharma (US) Corp.
Product to expire in March 2026; Discontinuation of the manufacture of the drug
Discontinuing Advanz Pharma (US) Corp.
Discontinuation of the manufacture of the drug product
Discontinuing Upsher-Smith Laboratories, LLC
Discontinuation of the manufacture of the drug
Discontinuing Pfizer Inc.
A business decision was made to discontinue manufacture of the drug.
Discontinuing Teva Pharmaceuticals USA, Inc.
A business decision was made to discontinue manufacture of the drug.
Discontinuing Mylan Pharmaceuticals Inc., a Viatris Company
A business decision was made to discontinue manufacture of the drug.
Discontinuing Teva Pharmaceuticals USA, Inc.
Discontinuation of the manufacture of the drug
Discontinuing Organon
Discontinuation of the manufacture of the drug
Discontinuing Hospira, Inc., a Pfizer Company
Discontinuation of the manufacture of the drug
Discontinuing Hospira, Inc., a Pfizer Company
Discontinuation of the manufacture of the drug
Discontinuing Teva Pharmaceuticals USA, Inc.
Discontinuation of the manufacture of the drug
Discontinuing Novo Nordisk, Inc.
A business decision was made to discontinue manufacture of the drug.
Discontinuing Actavis Pharma, Inc.
Discontinuation of the manufacture of the drug
Discontinuing Teva Pharmaceuticals USA, Inc.
Discontinuation of the manufacture of the drug
Discontinuing Teva Pharmaceuticals USA, Inc.
A business decision was made to discontinue manufacture of the drug.
Discontinuing Endo Pharmaceuticals, Inc.
Discontinuation of the manufacture of the drug
Discontinuing Hospira, Inc., a Pfizer Company
Discontinuation of the manufacture of the drug.
Discontinuing Chiesi USA, Inc.
Discontinuation of the manufacture of the drug
Discontinuing Pfizer Inc.
Discontinuation of the manufacture of the drug
Discontinuing Hospira, Inc., a Pfizer Company
Discontinuation of the manufacture of the drug
Discontinuing Hospira, Inc., a Pfizer Company
Discontinuation of the manufacture of the drug
Discontinuing Hospira, Inc., a Pfizer Company
Discontinuation of the manufacture of the drug
Discontinuing Hospira, Inc., a Pfizer Company
Discontinuation of the manufacture of the drug
Discontinuing Hospira, Inc., a Pfizer Company
Discontinuation of the manufacture of the drug
Discontinuing Padagis US LLC
Discontinuation of the manufacture of the drug
Discontinuing Endo Pharmaceuticals, Inc.
The global Cease Manufacture date for EVOTAZ® currently is estimated to begin April 2026.
Discontinuing Bristol Myers Squibb Co.
Discontinuation of the manufacture of the drug
Discontinuing Endo Pharmaceuticals, Inc.
A business decision was made to discontinue manufacture of the 50 mg and 100 mg tablets. Distribution will end on May 31, 2026.
Discontinuing Eli Lilly and Co.
Discontinuation of the manufacture of the drug
Discontinuing Endo Pharmaceuticals, Inc.
Discontinuation of the manufacture of the drug
Discontinuing Fresenius Kabi USA, LLC
Discontinuation of the manufacture of the drug.
Discontinuing AstraZeneca AB
Discontinuation of the manufacture of the drug.
Discontinuing Mylan Institutional, a Viatris Company
A business decision was made to discontinue manufacture of the drug.
Discontinuing Eli Lilly and Co.
A business decision was made to discontinue manufacture of the drug.
Discontinuing Eli Lilly and Co.
A business decision was made to discontinue manufacture of the drug.
Discontinuing Eli Lilly and Co.
Supply is expected to be depleted by 12/31/2025.
Discontinuing Teva Pharmaceuticals USA, Inc.
A business decision was made to discontinue manufacture of the drug.
Discontinuing Fresenius Kabi USA, LLC
To be discontinued December 1, 2025
Discontinuing Merck Sharp & Dohme LLC
Discontinuation of the manufacture of the drug
Discontinuing Pyros Pharmaceuticals, Inc.
Discontinuation of the manufacture of the drug
Discontinuing Sandoz Inc.
Discontinuation of the manufacture of the drug
Discontinuing Pfizer Inc.
Discontinuation of the manufacture of the drug
Discontinuing Sandoz Inc.
Discontinuation of the manufacture of the drug
Discontinuing Pfizer Inc.
Discontinuation of the manufacture of the drug
Discontinuing AbbVie Inc.
Gilead plans to sell through the end of February 2026. Discontinuation of the manufacture of the drug due to business reasons.
Discontinuing Gilead Sciences, Inc.
Discontinuation of the manufacture of the drug
Discontinuing Pfizer Inc.
Discontinuation of the manufacture of the drug
Discontinuing Pfizer Inc.
Discontinuation of the manufacture of the drug
Discontinuing Genentech, Inc
Discontinuation of the manufacture of the drug; Distributed by Sandoz Inc.
Discontinuing Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.)
Discontinuation of the manufacture of the drug upon exhausted supply/stop sale in December 2025.
Discontinuing Pfizer Inc.
Discontinuation of the manufacture of the drug.
Discontinuing Pfizer Inc.
A business decision was made to discontinue manufacture of the drug.
Discontinuing Ingenus Pharmaceuticals LLC
Discontinuation of the manufacture of the drug.
Discontinuing Actavis Pharma, Inc.
Business decision. Products will not be available after November 14, 2025.
Discontinuing Intercept Pharmaceuticals
Discontinuation of the manufacture of the drug.
Discontinuing Upsher-Smith Laboratories, LLC
Discontinuation of the manufacture of the drug.
Discontinuing Actavis Pharma, Inc.
Hikma has permanently discontinued (NDC 0054-0390-41) for the 15 mL bottle configuration. Hikma will continue to distribute Oxycodone Hydrochloride Oral Solution 5 mg/5 mL in the 500 mL bottle (NDC 0054-0390-63).
Discontinuing Hikma Pharmaceuticals USA, Inc.
Discontinuation of the manufacture of the drug
Discontinuing Hospira, Inc., a Pfizer Company
Discontinuing Teva Pharmaceuticals USA, Inc.
Discontinuation of the manufacture of the drug.
Discontinuing Pfizer Inc.
This product discontinuation is a business-related decision. The anticipated date that Prasco will cease distribution of the product is approximately March 16, 2026.
Discontinuing Prasco Laboratories
The 10 mg presentation remains available.
Discontinuing Sun Pharmaceutical Industries Limited
Discontinuation of the manufacture of the drug
Discontinuing Mylan Pharmaceuticals Inc., a Viatris Company
Discontinuation of the manufacture of the drug
Discontinuing Assertio Specialty Pharmaceuticals, LLC
Discontinuation of the manufacture of the drug
Discontinuing Pfizer Inc.
Discontinuation of the manufacture of the drug
Discontinuing Hospira, Inc., a Pfizer Company
Discontinuation of the manufacture of the drug product
Discontinuing Teva Pharmaceuticals USA, Inc.
Discontinuation of the manufacture of the drug
Discontinuing Teva Pharmaceuticals USA, Inc.
Discontinuation of the manufacture of the drug. Product expected to be available through July 2026.
Discontinuing Swedish Orphan Biovitrum AB
Discontinuation of the manufacture of the drug
Discontinuing Avet Pharmaceuticals, Inc.
Discontinuation of the manufacture of the drug
Discontinuing Leadiant Biosciences, Inc.
A business decision was made to discontinue manufacture of the product.
Discontinuing Teva Pharmaceuticals USA, Inc.
Discontinuation of the manufacture of the drug
Discontinuing Pfizer Inc.
Discontinuation of the manufacture of the drug
Discontinuing Apotex Corp.
Discontinuation of the manufacture of the drug
Discontinuing Pfizer Inc.
Discontinuation of the manufacture of the drug
Discontinuing Pfizer Inc.
Discontinuation of the manufacture of the drug product
Discontinuing Upsher-Smith Laboratories, LLC
Discontinuation of the manufacture of the drug product
Discontinuing Upsher-Smith Laboratories, LLC
Unbranded Insulin Aspart 3 mL FlexPen® will continue to be shipped to wholesalers while supplies last, up until the discontinuation dates. Full discontinuation will occur on December 31, 2025.
Discontinuing Novo Nordisk, Inc.
Unbranded Insulin Degludec 3 mL U-100 FlexTouch® will continue to be shipped to wholesalers while supplies last, up until the discontinuation dates. Full discontinuation will occur on December 31, 2025.
Discontinuing Novo Nordisk, Inc.
Unbranded Insulin Aspart Protamine and Insulin Aspart Mix 70/30 10 mL vial will continue to be shipped to wholesalers while supplies last, up until the discontinuation dates. Full discontinuation will occur on December 31, 2025.
Discontinuing Novo Nordisk, Inc.
Discontinuation of the manufacture of the drug.
Discontinuing Hospira, Inc., a Pfizer Company
Discontinuation of the manufacture of the drug.
Discontinuing Pfizer Inc.
Discontinuation is for the “NovaPlus” label product only.
Discontinuing Actavis Pharma, Inc.
A business decision was made to discontinue.
Discontinuing Watson Pharma Private Limited
Discontinuation of the manufacture of the drug.
Supply expected to exhaust September 2025
Discontinuing Pfizer Inc.
Discontinuation of the manufacture of the drug
Discontinuing EMD Serono, Inc.
Discontinuation of the manufacture of the drug
Discontinuing Hospira, Inc., a Pfizer Company
Product expected to be available until August 2025.
Discontinuing Genus Lifesciences
A business decision was made to discontinue manufacture of the product
Discontinuing Actavis Pharma, Inc.
Discontinuation of the manufacture of the drug
Discontinuing Teva Pharmaceuticals USA, Inc.
Permanent discontinuation in the manufacturing of the drug
Discontinuing Novartis Pharmaceuticals Corporation
A business decision was made to discontinue manufacture of the drug.
Discontinuing Ingenus Pharmaceuticals LLC
Discontinuation of the manufacture of the drug
Discontinuing Teva Pharmaceuticals USA, Inc.
Discontinuation of the manufacture of the drug
Discontinuing Actavis Pharma, Inc.
Discontinuation of the manufacture of the drug
Discontinuing Teva Pharmaceuticals USA, Inc.
Discontinuation of the manufacture of the drug
Discontinuing Mylan Pharmaceuticals Inc., a Viatris Company
Discontinuing Teva Pharmaceuticals USA, Inc.
Discontinuing Teva Pharmaceuticals USA, Inc.
A business decision was made to discontinue manufacture of the product.
Discontinuing Torrent Pharma Inc.
Discontinuing Teva Pharmaceuticals USA, Inc.
Discontinuing Teva Pharmaceuticals USA, Inc.
Discontinuing Teva Pharmaceuticals USA, Inc.
Discontinuation of the manufacture of the drug
Discontinuing Hospira, Inc., a Pfizer Company
Discontinuing Teva Pharmaceuticals USA, Inc.
Discontinuation of the manufacture of the drug
Discontinuing Teva Pharmaceuticals USA, Inc.
Discontinuation of the manufacture of the drug
Discontinuing Teva Pharmaceuticals USA, Inc.
Discontinuing Actelion Pharmaceuticals
Permanent discontinuation
Discontinuing Bristol Myers Squibb Co.
Permanent discontinuation
Discontinuing Bristol Myers Squibb Co.
Permanent discontinuation in the manufacturing of the drug
Discontinuing Aurobindo Pharma USA
Discontinuing Actavis Pharma, Inc.
Permanent discontinuation of manufacture due to business decision.
Discontinuing Teva Pharmaceuticals USA, Inc.
Permanent discontinuation of specific package size/ SKU for business reasons.
Discontinuing Teva Pharmaceuticals USA, Inc.
Discontinuing Teva Pharmaceuticals USA, Inc.
A business decision was made to discontinue the product.
Discontinuing Upsher-Smith Laboratories, LLC
Discontinuing Upsher-Smith Laboratories, LLC
A business decision was made to discontinue the product.
Discontinuing Upsher-Smith Laboratories, LLC
Discontinuing Upsher-Smith Laboratories, LLC
Discontinuation of the manufacture of the drug.
Discontinuing Hospira, Inc., a Pfizer Company
Discontinuing Upsher-Smith Laboratories, LLC
Discontinuing Upsher-Smith Laboratories, LLC
Discontinuation of manufacture of drug based on business decision.
Discontinuing Upsher-Smith Laboratories, LLC
Discontinuing Upsher-Smith Laboratories, LLC
Discontinuation of the manufacture of the drug. Supply expected to exhaust in August 2023
Discontinuing Pfizer Inc.
Upsher-Smith will continue to provide their generic Topiramate Extended-release Capsules.
Discontinuing Upsher-Smith Laboratories, LLC
Discontinuing Upsher-Smith Laboratories, LLC
Equivalent Sandoz format is available.
Discontinuing Sandoz Inc.
Discontinuing Sandoz Inc.
Discontinuation of the manufacture of the drug
Discontinuing Fresenius Kabi USA, LLC
Discontinuing Chiesi USA, Inc.
A business decision was made to discontinue manufacture of the drug.
Discontinuing Teva Pharmaceuticals USA, Inc.
Discontinuation of the manufacture of the drug
Discontinuing Ingenus Pharmaceuticals LLC
A business decision was made to discontinue.
Discontinuing Teva Pharmaceuticals USA, Inc.
Product is expected to be available through February 2027.
Discontinuing Takeda Pharmaceuticals USA Inc.
A business decision was made to discontinue manufacture of the drug.
Discontinuing Fresenius Kabi USA, LLC
The NDC codes are being discontinued, to be replaced with NDC labeler code #46163.
Discontinuing Fresenius Medical Care North America
Discontinuation of the manufacture of the drug
Discontinuing Janssen Pharmaceuticals
Discontinuation of the manufacture of the drug
Discontinuing Amneal Pharmaceuticals
Discontinuation of the manufacture of the drug
Discontinuing Pfizer Inc.
Discontinuation of the manufacture of the drug
Discontinuing Pfizer Inc.
A business decision was made to discontinue manufacture of the drug.
Discontinuing Ingenus Pharmaceuticals LLC
Discontinuation of the manufacture of the drug
Discontinuing Ingenus Pharmaceuticals LLC
Discontinuation of the manufacture of the drug
Discontinuing Teva Pharmaceuticals USA, Inc.
Discontinuation of the manufacture of the drug.
Discontinuing Fresenius Kabi USA, LLC
Discontinuation of the manufacture of the drug.
Discontinuing Pfizer Inc.
Discontinuing Salix Pharmaceuticals, a division of Bausch Health US, LLC
Discontinuation of the manufacture of the drug; Expiry date of last distributed batch January 2027
Discontinuing Sun Pharmaceutical Industries, Inc.
Discontinuation of the manufacture of the drug
Discontinuing AbbVie Inc.
Discontinuation of the manufacture of the drug
Discontinuing Sandoz Inc.
Discontinuation of the manufacture of the drug
Discontinuing Fresenius Kabi USA, LLC
Discontinuing manufacture of the product as of June 2026.
Discontinuing Glaukos Corporation
Discontinuation of the manufacture of the drug
Discontinuing Fresenius Kabi USA, LLC
The anticipated date that GSK will cease distribution of the product is approximately August 1, 2026.
Discontinuing ViiV Healthcare Company
Discontinuation of the manufacture of the drug
Discontinuing Fresenius Kabi USA, LLC
Discontinuation of the manufacture of the drug
Discontinuing Fresenius Kabi USA, LLC
A business decision was made to discontinue manufacture of the drug.
Discontinuing Mylan Pharmaceuticals Inc., a Viatris Company
To be discontinued in approximately mid-2026.
Discontinuing Merck Sharp & Dohme Corp.
Discontinuation of the manufacture of the drug
Discontinuing Hospira, Inc., a Pfizer Company
Discontinuation of the manufacture of the drug
Discontinuing Teva Pharmaceuticals USA, Inc.
Recently Resolved (5) Resolved Baxter Healthcare
Lactated Ringers Injection
Resolved Otsuka ICU Medical LLC
Methamphetamine Hydrochloride Tablet
Resolved Hikma Pharmaceuticals USA, Inc.
Shortage Record Fields FDA status
FDA source records identify the reported shortage status and update date.
Product details
Available records preserve reported dosage forms, presentations, and manufacturers.
Registry boundary
PlainMeds displays the source record and does not recommend substitutions, procurement, or treatment changes.
Frequently Asked Questions What causes drug shortages? Drug shortages can result from manufacturing problems, quality issues, supply disruptions, raw material shortages, or increased demand. The FDA tracks and works to resolve these shortages.
How often is this data updated? This page uses data from the FDA Drug Shortages Database. The database is refreshed periodically to reflect the latest shortage information from the FDA.
What should I do if my medication is in shortage? Contact your pharmacist or prescriber. They may be able to find an alternative manufacturer, suggest a therapeutic substitute, or help you locate available supply.
Does a shortage mean I cannot get my medication? Not necessarily. A shortage means supply is limited, but pharmacies may still have stock from other manufacturers. Your pharmacist can check availability across suppliers.
Shortage Data Methodology
Shortage records are pulled directly from
FDA Drug Shortages Database openFDA API FDA SPL labels full methodology page for data vintage, processing pipeline, and interpretation caveats.
Disclaimer: This page provides information from the FDA Drug Shortages Database for educational purposes only.
It is a source-record index and does not provide medication availability, treatment, or substitution directions.
Do not stop or change any medication without professional guidance.
What an FDA shortage listing means
Shortages are tracked at the manufacturer and presentation level. Other manufacturers or formulations of the same generic may remain available, which is why pharmacists often can source a working substitute even when one record is flagged. A shortage listing is a supply-side signal, not a patient-level instruction.
Access can vary by pharmacy, region, hospital system, and insurance formulary. Local pharmacists have real-time visibility that a national database cannot provide. Therapeutic substitutes often exist in the same class, but switching decisions belong with your prescriber, who weighs efficacy, dosing conversion, interaction profile, and personal history.
This tracker summarizes public FDA data for educational reference only and is not medical advice. If your medication is affected, contact your pharmacist and prescriber to plan an appropriate response.
Cite this page PlainMeds, “FDA Drug Shortage Tracker.” Compiled from FDA Drug Shortages Database; data as of 2026-05-15.
https://plainmeds.com/shortages
Formal citation formats (APA / MLA) APA: PlainMeds. (2026). FDA Drug Shortage Tracker. Retrieved September 11, 2026 , from https://plainmeds.com/shortages
MLA: "FDA Drug Shortage Tracker." PlainMeds, 2026, https://plainmeds.com/shortages.
You are welcome to quote these figures with attribution to PlainMeds and the underlying source. The URL above is stable.
See our Terms of Use for what reuse is permitted.